Long-term outcome of medical and surgical therapies for gastroesophageal reflux disease: follow-up of a randomized controlled trial.
By S. Spechler, Edward S. Lee, D. Ahnen, R. Goyal, I. Hirano, F. Ramirez, J. Raufman, Richard Sampliner, T. Schnell, S. Sontag and 3 more. Journal of the American Medical Association (JAMA), 2001
932 citations recorded by the source corpus.
Subfields: Gastroenterology, Surgery
View Paper: https://www.semanticscholar.org/paper/5a546d4520ed31a133b76b6739d1d29400f8b6e5
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- E. Hassall
- G. Veereman‐Wauters
- A. Staiano
- C. Rudolph
- T. Wenzl
- C. Di Lorenzo
- L. Mazur
- G. Liptak
Citations in the corpus
- Pediatric Gastroesophageal Reflux Clinical Practice Guidelines: Joint Recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN) (2009, background): “In a large multicenter controlled study, 62% of the adults were taking PPIs for reflux symptoms 7 years after antireflux surgery (381).”